From there, your provider may discuss nutrition, movement, coaching, labs, prescription medications, or related wellness care
SCORE was a real-world study in the US that analysed MACE outcomes among Wegovy (semaglutide 2.4 mg) users and non-users in real-world clinical practice, who met similar inclusion criteria as in the SELECT trial and were aged 45 years with overweight or obesity and established CVD without diabetes.
Versatility in Choices : With options ranging from ready-to-eat snacks to ingredients for homemade meals, theres something for everyone, regardless of dietary preferences or time constraints
Patients with a history or pancreatitis, personal or family history of medullary thyroid cancer, multiple endocrine neoplasia 2A or 2B, or diabetic retinopathy should not take semaglutide